Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
33.17 USD | +0.58% | -8.06% | +54.18% |
May. 15 | Spyre Therapeutics, Inc. Announces Board Changes | CI |
May. 13 | Wells Fargo Adjusts Price Target on Spyre Therapeutics to $40 From $35, Maintains Overweight Rating | MT |